Buy, Sell, or Hold Axsome Therapeutics Stock After Its FDA Approval Delay?

Axsome Therapeutics (NASDAQ: AXSM) recently announced that the U.S. Food and Drug Administration (FDA) wouldn't make an approval decision on AXS-05 for treating major depressive disorder as quickly as hoped. In this Motley Fool Live video recorded on Aug. 25, 2021, Motley Fool contributors Keith Speights and Brian Orelli discuss whether Axsome stock is a buy, sell, or hold after this FDA delay.

Continue reading

Source Fool.com